LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
40 hedge funds and large institutions have $138M invested in LogicBio Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
16% less capital invested
Capital invested by funds: $165M → $138M (-$26.7M)
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$848K | |
| 2 | +$438K | |
| 3 | +$256K | |
| 4 |
BlackRock
New York
|
+$166K |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$156K |
Top Sellers
| 1 | -$712K | |
| 2 | -$108K | |
| 3 | -$46.8K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$41K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$32K |